Intellia Therapeutics (NTLA)
Nasdaq • NTLA • US45826J1051
12.31Last close
Market Closed
Nasdaq • NTLA • US45826J1051
Intellia Therapeutics (Nasdaq: NTLA) has a market capitalization of $1.72B. Last close $12.31 (as of 2026-11-05); 52-week range $7.95 to $18.48. ORTEX data as of 2026-10-20: short interest is 33.97% of free float, 7.7 days to cover and the average cost to borrow is 0.45%.